CellbXhealth (CLBX)

Sector:

Support

Index:

FTSE AIM All-Share

2.20p
   
  • Change Today:
      0.100p
  • 52 Week High: 16.50
  • 52 Week Low: 1.75
  • Currency: UK Pounds
  • Shares Issued: 322.64m
  • Volume: 758,170
  • Market Cap: £7.10m
  • Beta: 0.57

CellbXhealth Overview

CellbXhealth is a world leading liquid biopsy company with sample to answer solutions. ANGLE’s proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

1 Day Chart (05-11-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CellbXhealth Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.76 (13.74) (6.51)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.01 (17.36) (6.66)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.04 (24.44) (8.96)p n/a n/a n/a n/a 0.0%
31-Dec-23 2.19 (21.63) (7.72)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 2.86 (15.03) (4.82)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CellbXhealth Company Announcements

Further Update on Funding 05-Nov-2025 18:16 RNS
Expert Consensus on CTCs; Update on Funding 04-Nov-2025 07:00 RNS
Appointments: Interim CEO and senior board advisor 16-Oct-2025 07:00 RNS

CellbXhealth ShareCast News

Angle founder and CEO steps down after sharehold... 12-Sep-2025 ShareCast
Shares in Angle tumble on gloomy outlook 09-Sep-2025 ShareCast
Angle reviewing board structure as two directors... 06-Jun-2025 ShareCast

CellbXhealth Top Newspaper Links

New Angle for Braveheart 26-Jan-2009 The Scotsman

Latest CellbXhealth Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CellbXhealth Market Data

Currency UK Pounds
Share Price 2.20p
Change Today 0.100p
% Change 4.76 %
52 Week High 16.50
52 Week Low 1.75
Volume 758,170
Shares Issued 322.64m
Market Cap £7.10m
Beta 0.57

CellbXhealth Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average
36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average
Price Trend
85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Income Not Available
Growth
54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average
56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average

CellbXhealth Dividends

No dividends found

Trades for 05-Nov-2025

Time Volume / Share Price
17:06 100,000 @ 2.20p
16:29 6,050 @ 2.24p
16:16 31,250 @ 2.24p
16:12 6,000 @ 2.24p
16:02 4,200 @ 2.14p

CellbXhealth Key Personnel

Chair Jan Groen

Top of Page